News
- INNATE PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating Innate Pharma S.A. on Behalf of Innate Stockholders and Encourages Investors to Contact the Firm
10/24/2020 / 02:00 - GlobeNewswire
-
- BAK FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Braskem S.A. Investors of Important October 26 Deadline in Securities Class Action – BAK
10/24/2020 / 01:44 - GlobeNewswire
-
- Nestle's sales drop 9.4% in 9M 2020 to 61.9B Swiss francs
10/21/2020 / 07:21 - TeleTrader
-
- FourKites to Host First-Ever Virtual Conference Focused on Supply Chain Visibility and Logistics Operations in Latin America
10/15/2020 / 13:30 - GlobeNewswire
-
- Publicis Groupe: Third Quarter 2020 Revenue
10/15/2020 / 07:30 - GlobeNewswire
-
- Nestle: Offer accepted by Aimmune stockholders
10/13/2020 / 08:56 - TeleTrader
-
- Auxly Strengthens its Board and Announces Additional Steps on Path to Profitability
10/01/2020 / 13:30 - GlobeNewswire
-
- Groupe PSA and FCA announce Stellantis Board membership
09/29/2020 / 08:30 - GlobeNewswire
-
- SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers
09/23/2020 / 21:00 - GlobeNewswire
-
- Lifshitz Law Firm, P.C. Announces Investigation of Aimmune Therapeutics, Inc., (NASDAQ:AIMT), Akcea Therapeutics, Inc., (NASDAQ:AKCA), BMC Stock Holdings, Inc., (NASDAQ:BMCH), and Cancer Genetics, Inc., (NASDAQ:CGIX)
09/16/2020 / 19:24 - GlobeNewswire
Real-time